<!-- html table generated in R 3.2.0 by xtable 1.7-4 package -->
<!-- Thu Jun 11 18:16:05 2015 -->
<table border=1>
<tr> <th>  </th> <th> GOBPID </th> <th> Pvalue </th> <th> OddsRatio </th> <th> ExpCount </th> <th> Count </th> <th> Size </th> <th> Term </th> <th> Genes </th>  </tr>
  <tr> <td> 1 </td> <td align="center"> GO:0051224 </td> <td align="right"> 0.02 </td> <td align="right"> 3.57 </td> <td align="right"> 1.49 </td> <td align="right">   5 </td> <td align="right"> 112 </td> <td> negative regulation of protein transport </td> <td> LYPLA1, LILRB1, CYLD, RHBDF2, DYRK2 </td> </tr>
  <tr> <td> 2 </td> <td align="center"> GO:0045088 </td> <td align="right"> 0.02 </td> <td align="right"> 2.91 </td> <td align="right"> 2.19 </td> <td align="right">   6 </td> <td align="right"> 164 </td> <td> regulation of innate immune response </td> <td> LILRB1, CYLD, IFNGR1, PDPK1, SUSD4, TLR5 </td> </tr>
  <tr> <td> 3 </td> <td align="center"> GO:1903037 </td> <td align="right"> 0.05 </td> <td align="right"> 2.61 </td> <td align="right"> 2.01 </td> <td align="right">   5 </td> <td align="right"> 151 </td> <td> regulation of leukocyte cell-cell adhesion </td> <td> LILRB1, CYLD, NCK1, PDPK1, SASH3 </td> </tr>
  <tr> <td> 4 </td> <td align="center"> GO:0034110 </td> <td align="right"> 0.06 </td> <td align="right"> 2.48 </td> <td align="right"> 2.11 </td> <td align="right">   5 </td> <td align="right"> 158 </td> <td> regulation of homotypic cell-cell adhesion </td> <td> LILRB1, CYLD, NCK1, PDPK1, SASH3 </td> </tr>
  <tr> <td> 5 </td> <td align="center"> GO:0032147 </td> <td align="right"> 0.06 </td> <td align="right"> 2.45 </td> <td align="right"> 2.13 </td> <td align="right">   5 </td> <td align="right"> 160 </td> <td> activation of protein kinase activity </td> <td> TOM1L1, KRAS, PDPK1, PRKACB, BMP2 </td> </tr>
  <tr> <td> 6 </td> <td align="center"> GO:0051249 </td> <td align="right"> 0.05 </td> <td align="right"> 2.41 </td> <td align="right"> 2.61 </td> <td align="right">   6 </td> <td align="right"> 196 </td> <td> regulation of lymphocyte activation </td> <td> LILRB1, CYLD, NCK1, PDPK1, SASH3, LST1 </td> </tr>
  <tr> <td> 7 </td> <td align="center"> GO:0007411 </td> <td align="right"> 0.10 </td> <td align="right"> 1.86 </td> <td align="right"> 3.92 </td> <td align="right">   7 </td> <td align="right"> 294 </td> <td> axon guidance </td> <td> ACTR2, EFNB2, KIF5C, KRAS, NCK1, TIAM1, ZIC2 </td> </tr>
  <tr> <td> 8 </td> <td align="center"> GO:0006396 </td> <td align="right"> 0.07 </td> <td align="right"> 1.83 </td> <td align="right"> 5.14 </td> <td align="right">   9 </td> <td align="right"> 386 </td> <td> RNA processing </td> <td> SRRM1, PAPD4, DHX36, HNRNPA2B1, PRPF40A, RP9, SF1, SLBP, SCAF11 </td> </tr>
  <tr> <td> 9 </td> <td align="center"> GO:0051726 </td> <td align="right"> 0.05 </td> <td align="right"> 1.78 </td> <td align="right"> 7.77 </td> <td align="right">  13 </td> <td align="right"> 583 </td> <td> regulation of cell cycle </td> <td> TOM1L1, LILRB1, NACC2, CTBP1, CYLD, CCNY, TMOD3, PRPF40A, PRKACB, BIRC6, RBL2, BMP2, KAT2B </td> </tr>
  <tr> <td> 10 </td> <td align="center"> GO:0008285 </td> <td align="right"> 0.10 </td> <td align="right"> 1.76 </td> <td align="right"> 4.72 </td> <td align="right">   8 </td> <td align="right"> 359 </td> <td> negative regulation of cell proliferation </td> <td> NACC2, CTBP1, EFNB2, FABP7, BMP2, SF1, KAT2B, CD33 </td> </tr>
  <tr> <td> 11 </td> <td align="center"> GO:0097190 </td> <td align="right"> 0.10 </td> <td align="right"> 1.72 </td> <td align="right"> 5.46 </td> <td align="right">   9 </td> <td align="right"> 410 </td> <td> apoptotic signaling pathway </td> <td> ARL6IP5, NACC2, CYLD, NCK1, PDPK1, BIRC6, TIAM1, DYRK2, ACVR1B </td> </tr>
  <tr> <td> 12 </td> <td align="center"> GO:0002684 </td> <td align="right"> 0.09 </td> <td align="right"> 1.69 </td> <td align="right"> 6.20 </td> <td align="right">  10 </td> <td align="right"> 465 </td> <td> positive regulation of immune system process </td> <td> ACTR2, LILRB1, CYLD, NCK1, PDPK1, SASH3, SUSD4, TLR5, CA2, ACVR1B </td> </tr>
  <tr> <td> 13 </td> <td align="center"> GO:0006955 </td> <td align="right"> 0.05 </td> <td align="right"> 1.65 </td> <td align="right"> 10.31 </td> <td align="right">  16 </td> <td align="right"> 774 </td> <td> immune response </td> <td> ACTR2, IPO7, LILRB1, CYLD, DHX36, IFNGR1, KRAS, NCK1, PDPK1, SASH3, SUSD4, PRKACB, HAMP, TLR5, LST1, SPPL2A </td> </tr>
  <tr> <td> 14 </td> <td align="center"> GO:0051336 </td> <td align="right"> 0.09 </td> <td align="right"> 1.56 </td> <td align="right"> 9.43 </td> <td align="right">  14 </td> <td align="right"> 708 </td> <td> regulation of hydrolase activity </td> <td> ARL6IP5, CST3, ITSN2, ASAP1, PDPK1, SERPINB6, PRKACB, BIRC6, ARHGAP9, RGS18, BMP2, WNK1, TIAM1, DENND1C </td> </tr>
  <tr> <td> 15 </td> <td align="center"> GO:0007166 </td> <td align="right"> 0.09 </td> <td align="right"> 1.38 </td> <td align="right"> 22.61 </td> <td align="right">  29 </td> <td align="right"> 1697 </td> <td> cell surface receptor signaling pathway </td> <td> ACTR2, LILRB1, CYLD, ATP6V0E2, EFNB2, CCNY, PEG10, NPB, ADGRD1, TMEM145, IFNGR1, ITGB8, KRAS, NCK1, PDPK1, PRKACB, BIRC6, CEACAM1, RGS18, BMP2, TIAM1, CA2, CPEB4, DYRK2, CBL, KAT2B, ACVR1B, USP34, P2RY14 </td> </tr>
   </table>
